Terms: = Breast cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
196 results:
1. Colorimetric and Electrochemical Dual-Mode Detection of Thioredoxin 1 Based on the Efficient Peroxidase-Mimicking and Electrocatalytic Property of Prussian Blue Nanoparticles.
Kim JU; Kim JM; Thamilselvan A; Nam KH; Kim MI
Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667178
[TBL] [Abstract] [Full Text] [Related]
2. Mucocele-like Lesions: Radiologic-Pathologic Correlation.
Chandora A; Kahn AG; Zamora K
J Breast Imaging; 2024 Apr; 6(2):175-182. PubMed ID: 38394371
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2.
Velez J; Dale B; Park KS; Kaniskan HÜ; Yu X; Jin J
Eur J Med Chem; 2024 Mar; 267():116154. PubMed ID: 38295690
[TBL] [Abstract] [Full Text] [Related]
4. Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines.
Baranoski A; Semprebon SC; Biazi BI; Zanetti TA; Corveloni AC; Areal Marques L; Lepri SR; Coatti GC; Mantovani MS
J Toxicol Environ Health A; 2024 Apr; 87(7):294-309. PubMed ID: 38279841
[TBL] [Abstract] [Full Text] [Related]
5. Spectrum of Mucin-containing Lesions of the breast: Multimodality Imaging Review with Pathologic Correlation.
Thai JN; Lerwill MF; Chou SS
Radiographics; 2023 Oct; 43(10):e230015. PubMed ID: 37792588
[TBL] [Abstract] [Full Text] [Related]
6. Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy.
Blayney DW; Kuderer NM; Cummings Joyner AK; Jarvis J; Nunag D; Wells J; Huang L; Monhanlal R; Lyman GH
J Natl Compr Canc Netw; 2023 Sep; 21(9):945-950.e16. PubMed ID: 37673111
[TBL] [Abstract] [Full Text] [Related]
7. Menin-mll1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
Shi Q; Xu M; Kang Z; Zhang M; Luo Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
[TBL] [Abstract] [Full Text] [Related]
8. Targeting mll Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive breast cancer.
Jones RB; Farhi J; Adams M; Parwani KK; Cooper GW; Zecevic M; Lee RS; Hong AL; Spangle JM
Cancer Res Commun; 2022 Dec; 2(12):1569-1578. PubMed ID: 36970726
[TBL] [Abstract] [Full Text] [Related]
9. FOXQ1 recruits the mll complex to activate transcription of EMT and promote breast cancer metastasis.
Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
[TBL] [Abstract] [Full Text] [Related]
10. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the mll Complex in breast cancer Cells.
Hernández-Quiles M; Baak R; Orea-Soufi A; Borgman A; den Haan S; Sobrevals Alcaraz P; Jongejan A; van Es R; Velasco G; Vos H; Kalkhoven E
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142452
[TBL] [Abstract] [Full Text] [Related]
11. Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation.
Cai WL; Chen JF; Chen H; Wingrove E; Kurley SJ; Chan LH; Zhang M; Arnal-Estape A; Zhao M; Balabaki A; Li W; Yu X; Krop ED; Dou Y; Liu Y; Jin J; Westbrook TF; Nguyen DX; Yan Q
Elife; 2022 Aug; 11():. PubMed ID: 36043466
[TBL] [Abstract] [Full Text] [Related]
12. MiR-143-3p Increases the Radiosensitivity of breast cancer Cells Through FGF1.
Wang D; Wang C; Sun L; Lu X; Shi J; Chen J; Zhang X
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):256-262. PubMed ID: 35818245
[TBL] [Abstract] [Full Text] [Related]
13. Mucocele-like Lesions of the breast.
Solomon WT; Dale PS
Am Surg; 2022 Sep; 88(9):2248-2249. PubMed ID: 35674064
[TBL] [Abstract] [Full Text] [Related]
14. [Primary lung salivary gland-type duct carcinoma: a clinicopathological analysis of two cases and review of literature].
Li SL; Wu CY; Hou LK; Xie HK; Wu W; Zhang W; Zhang LP
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):218-223. PubMed ID: 35249285
[No Abstract] [Full Text] [Related]
15. Evidence from a breastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer.
Noguchi N; Marinovich ML; Wylie EJ; Lund HG; Houssami N
Breast; 2022 Apr; 62():16-21. PubMed ID: 35114637
[TBL] [Abstract] [Full Text] [Related]
16. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract] [Full Text] [Related]
17. Pumpless three-dimensional photo paper-based microfluidic analytical device for automatic detection of thioredoxin-1 using enzyme-linked immunosorbent assay.
Lee MJ; Soum V; Lee SN; Choi JH; Shin JH; Shin K; Oh BK
Anal Bioanal Chem; 2022 Apr; 414(10):3219-3230. PubMed ID: 34767053
[TBL] [Abstract] [Full Text] [Related]
18. Mucin Neovascularization as a Diagnostic Aid to Distinguish Mucinous Carcinomas From Mucocele-like Lesions in breast Core Needle Biopsies.
Onken AM; Collins LC; Schnitt SJ
Am J Surg Pathol; 2022 May; 46(5):637-642. PubMed ID: 34545857
[TBL] [Abstract] [Full Text] [Related]
19. Mucocele-like lesions of the breast - A radiological and clinicopathological analysis.
Griffiths R; Alarcon L; Bonello V; Scott V; Szollosi Z
Curr Probl Cancer; 2021 Dec; 45(6):100762. PubMed ID: 34158182
[TBL] [Abstract] [Full Text] [Related]
20. Mucocele-like Lesion of the breast Diagnosed on Core Biopsy.
Towne WS; Michaels AY; Ginter PS
Arch Pathol Lab Med; 2022 Jan; 146(2):213-219. PubMed ID: 33929495
[TBL] [Abstract] [Full Text] [Related]
[Next]
